K. Sasamoto

Dropout of young non-insulin-dependent diabetics from diabetic care.

Y. Omori, M. Yoshino, R. Kawahara, 1994, Diabetes research and clinical practice.

Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.

T. Yanagawa, S. Shirabe, K. Sasamoto, 2004, Metabolism: clinical and experimental.

Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2018, Diabetology International.

Analysis of the effect of seasonal administration on the efficacy of sitagliptin: Subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes Study

Taku Kudo, H. Sakura, Y. Iwamoto, 2018, Journal of diabetes investigation.

Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Taku Kudo, H. Sakura, Y. Iwamoto, 2016, BMC Endocrine Disorders.

Renal Function During an Open-Label Prospective Observational Trial of Sitagliptin in Patients With Diabetes: A Sub-Analysis of the JAMP Study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2017, Journal of clinical medicine research.

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2017, Diabetology International.

Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients.

T. Yanagawa, S. Yamada, K. Sasamoto, 2006, Metabolism: clinical and experimental.